Cencora appointed Robert Sanchez as analysts cite USD 372.07 target for Cencora stock
Published on 10/12/2026 at 11:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Cencora appointed Robert E. Sanchez as an independent director effective October 1, 2026.
- MarketBeat cited a consensus target of USD 372.07 from 13 Buy and three Hold ratings.
- Fiscal third-quarter revenue reached USD 84.75 billion, while GAAP diluted earnings per share was USD 3.94.
- Cencora stock was at EUR 289.55 at Lang & Schwarz on October 12, 2026 at 11:06 a.m. CEST.
Cencora Inc. (ISIN US03073E1055) appointed Robert E. Sanchez as an independent director on September 25, 2026, effective October 1, according to Business Wire. On October 9, 2026, MarketBeat cited 13 Buy ratings and three Holds, with a consensus target of USD 372.07.
Three dated company developments
The chronology starts on August 5, 2026, when Cencora reported fiscal third-quarter revenue of USD 84.75 billion and adjusted earnings per share of USD 4.48, according to MarketBeat. On September 25, Cencora announced one new independent director, and on October 2 it scheduled the fiscal fourth-quarter results for November 4, 2026, before the New York Stock Exchange opened, according to Cencora.
What does the next report put on the calendar?
Cencora plans to publish fiscal fourth-quarter results on November 4, 2026, before trading starts on the New York Stock Exchange. The company also scheduled its earnings call for 8:30 a.m. ET on the same date, giving investors a defined date for the next revenue, profit and guidance update.
How much did the quarter deliver?
The fiscal third-quarter revenue figure represented a 5.10 percent year-over-year increase, while GAAP diluted earnings per share was USD 3.94 versus USD 3.52 in the prior-year quarter, according to Business Wire. The comparison matters because the reported GAAP earnings-per-share increase was 11.93 percent, calculated from USD 3.52 to USD 3.94, while the adjusted figure of USD 4.48 exceeded the USD 4.35 consensus cited by MarketBeat.
EUR 289.55 at Lang & Schwarz
Cencora stock was trading at EUR 289.55 at Lang & Schwarz on October 12, 2026 at 11:06 a.m. CEST. The market capitalization was USD 63.0 billion on October 9, 2026, while the primary-exchange one-year range was USD 244.82 to USD 377.54.
The further course of trading is shown by the continuously updated real-time quote of Cencora stock.
Cencora stock facts
- Company: Cencora, Inc.
- ISIN: US03073E1055
- Ticker: COR
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 12, 2026, 11:06 a.m. CEST: EUR 289.55
- Market capitalization: USD 63.0 billion as of October 9, 2026
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: S&P 500
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
